Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A distinct subpopulation within CD133 positive brain tumor cells shares characteristics with endothelial progenitor cells.

Cancer letters - 28 Nov 2012

Choi Seung Ah, Wang Kyu-Chang, Phi Ji Hoon, Lee Ji Yeoun, Park Chul-Kee, Park Sung-Hye, Kim Seung-Ki

Abstract excerpt

The cell surface marker CD133 has been proposed as a brain tumor stem cell marker. However, there have been substantial controversies regarding the necessity and role of CD133 in tumorigenesis. This study aimed to characterize CD133(+) cells in brain tumors. Human brain tumor specimens and whole blood were collected from the same patients (N=12). We carried out dual FACS staining for CD133/CD34 and functional...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to AC133 Antigen
Share to Antigens, CD34

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Lipoproteins, LDL

Share to Neoplastic Stem Cells

Share to Neovascularization, Physiologic

Share to Platelet Endothelial Cell Adhesion Molecule-1

Share to Spheroids, Cellular

Share to von Willebrand Factor

Source

Identifiers

PMID: 22652175
DOI: 10.1016/j.canlet.2012.05.026

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A distinct subpopulation within CD133 positive brain tumor cells shares characteristics with endothelial progenitor cells.PMID 22652175Read ↗

Content of stem tumor CD133+ cells in brain neoplasms of different histological type.Semantic proximity Read ↗

Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomasSemantic proximity Read ↗

CD133+ Glioblastoma Stem-Like Cells Induce Vascular Mimicry in VivoSemantic proximity Read ↗

CD133+ niches and single cells in glioblastoma have different phenotypes.Semantic proximity Read ↗

CD133+cells isolated from various sources and their role in future clinical perspectivesSemantic proximity Read ↗

CD133 Is Essential for Glioblastoma Stem Cell MaintenanceSemantic proximity Read ↗

CD133+ and CD133− Glioblastoma-Derived Cancer Stem Cells Show Differential Growth Characteristics and Molecular ProfilesSemantic proximity Read ↗

CD133 Is Not Present on Neurogenic Astrocytes in the Adult Subventricular Zone, but on Embryonic Neural Stem Cells, Ependymal Cells, and Glioblastoma CellsSemantic proximity Read ↗

Brain tumor stem cells: The cancer stem cell hypothesis writ largeSemantic proximity Read ↗

Identification of diverse tumor endothelial cell populations in malignant gliomaSemantic proximity Read ↗

Glial progenitor-like phenotype in low-grade glioma and enhanced CD133-expression and neuronal lineage differentiation potential in high-grade glioma.Semantic proximity Read ↗

Vascular Transdifferentiation in the CNS: A Focus on Neural and Glioblastoma Stem‐Like CellsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.